Medicine

The Pope, during a visit to the French shrine town of Lourdes, declared that 'medicine must never be servant of programmed death', a pointed comment on debates over euthanasia and assisted dying. The remark came in the context of the shrine's association with healing and pilgrimage, and it signals the Vatican's continued opposition to legalised ending of life on medical grounds.

The Trump administration is retreating from a plan to exert greater control over National Institutes of Health grant decisions after significant pushback. A proposed executive order that would have increased White House oversight of NIH funding appears to be dead, according to reporting by Semafor, marking a setback for efforts to centralise control of federal biomedical research grants.

Moderna has begun a Phase 1 clinical trial of an Ebola vaccine targeting the Zaire strain responsible for the outbreak in the Democratic Republic of the Congo. The trial marks the first human testing of the candidate, which uses the same mRNA technology behind Moderna's COVID-19 vaccine. Coverage is highlighting the company's growing pipeline and the urgent need for new Ebola countermeasures in central Africa.

Doctors are warning that people taking GLP-1 weight-loss and diabetes drugs such as Ozempic may face heightened health risks during the current heat wave. Concerns center on dehydration, as the medications can suppress thirst and appetite, potentially leaving users vulnerable to heat exhaustion and related complications. Patients are being advised to drink water regularly and take precautions in high temperatures as extreme heat persists across many regions.

Stanford Medicine is being widely cited for a claim that the human brain is actually two organs rather than one. The finding, reported by KRON 4, has drawn large public attention as audiences debate what a two-organ model would mean for neuroscience and medicine. Details of the underlying research have not been made available in the coverage cited.

Japan is considering stricter regulations on regenerative medicine as treatments in the field proliferate across the country. The move follows growing concern that clinics are offering unproven therapies under looser rules than those governing conventional drugs. Officials are debating how to balance patient access to innovative treatments with safety oversight, and medical groups are watching closely for what the revised framework could mean for practice.

Maternal-fetal medicine specialists have published new clinical standards for managing high-risk pregnancies in states with abortion bans. The guidelines aim to clarify when interventions are legally permissible and medically necessary, addressing confusion among physicians treating endangered patients. The move responds to reports of delayed or denied care, and is likely to fuel ongoing debate over how restrictive abortion laws affect pregnancy treatment.

An obesity medicine doctor is addressing the growing trend of taking small, lower-than-prescribed doses of Ozempic, the weight-loss and diabetes drug semaglutide. The expert explains the potential risks of adjusting doses without medical guidance, including reduced effectiveness and side effects, while noting the limited circumstances where a low dose may genuinely make sense for some patients.

Atrial fibrillation patients who take common blood thinners saw a 69% lower risk, according to newly reported findings circulating in health news. The claim concerns widely used anticoagulants and their protective effect in people with the heart rhythm condition. No further details on the study's size, population or methodology were available in the coverage, so the exact scope of the finding remains to be confirmed.

A debate is unfolding over legal accountability when artificial intelligence systems make errors in medical care. As AI tools move into diagnosis, treatment recommendations and clinical workflows, doctors, hospitals and technology developers are all potential defendants. The core question: does responsibility rest with the physician who followed the algorithm, the hospital that deployed it, or the company that built it. Legal frameworks have not kept pace.

Researchers have identified a new potential treatment target for high blood pressure, a condition affecting over a billion people worldwide and a leading risk factor for heart disease and stroke. The discovery could open the door to new drug development beyond existing blood pressure medications. Details of the findings and their clinical significance remain limited.

GLP-1 weight-loss drugs such as Ozempic and Wegovy are reshaping sleep medicine, with clinicians reporting improved sleep apnea symptoms in patients losing significant weight and drugmakers seeking apnea indications. Sleep specialists are debating whether medication could reduce reliance on CPAP machines, while researchers caution that long-term effects on sleep disorders remain largely unstudied.

A federal bill has been proposed that would ban the corporate practice of medicine across the United States. If enacted, the legislation would restrict corporations from owning or employing physicians, a model that has expanded rapidly through private equity investment in healthcare. Law firms and healthcare industry observers are examining the proposal's potential effects on hospital ownership, staffing companies and patient care.

New reporting indicates that people with insomnia face a higher risk of stroke, adding to growing evidence that sleep problems affect long-term cardiovascular health. The findings are being discussed as a reminder that chronic sleeplessness should be treated as a medical concern rather than a minor annoyance, with potential implications for prevention and patient screening.

New research reported by SciTechDaily suggests that losing the same amount of weight does not produce identical health benefits for everyone. The findings point to individual variation in how the body responds to weight loss, meaning two people with the same result may see different improvements in metabolic or cardiovascular health. The story is drawing attention for challenging the assumption that weight loss alone reliably translates into uniform health gains.

Insilico Medicine has signed a co-development deal worth tens of millions of dollars with an unnamed foundation-model laboratory, joining forces to apply large AI models to drug discovery. The Hong Kong-based biotech, known for using generative AI to design drug candidates, has not disclosed its partner or the exact terms, leaving observers speculating about which AI lab is behind the agreement.

Feverish babies admitted to hospital are often assumed to have a serious bacterial infection and are treated with antibiotics as a precaution. A new test that gauges whether an infection is bacterial or viral could reduce unnecessary antibiotic use in infants, helping doctors avoid overprescription and supporting efforts against antimicrobial resistance.

A South China Morning Post piece examines the risks of combining traditional Chinese medicine with Western prescription drugs, warning that interactions between herbal remedies and pharmaceuticals can reduce drug effectiveness or cause harmful side effects. The article urges patients to tell their doctors about any herbal treatments they use, as these are often undisclosed and can interact with common medications.

Physicians are pushing back on hantavirus coverage, arguing news headlines have exaggerated the actual risk to the public. In other medical news, three people have been sentenced in a Moscow-based telemedicine fraud scheme worth roughly $2 billion, and new figures show one in ten surgeons leave the profession within eight years. The stories are circulating in a medical news roundup.

Platform trials, which test multiple treatments against a single control group, are changing how clinical evidence is generated in medicine. Commentators argue that regulators have not yet adapted their standards to this trial design, raising questions about how such evidence will be assessed for drug approvals.

Heidi Overton, President Trump's nominee for FDA Commissioner, faced questioning from Senator Maggie Hassan at her confirmation hearing. Hassan pressed her on whether she would refuse an unlawful or improper directive from Trump, but Overton declined to entertain the possibility that the president could be wrong, drawing criticism that she would not commit to independent decision-making at the agency that regulates drugs and medical products.

A recall of a thyroid medication has been designated at the FDA's most serious risk level, known as Class I, reserved for situations where exposure could cause serious health problems or death. People with thyroid conditions are being advised to check their medication lots and contact their pharmacist or doctor if affected.

Minnesota Vikings wide receiver Justin Jefferson exited the team's game against the Tampa Bay Buccaneers after suffering an ankle injury. The severity of the injury was not immediately clear, and fans await updates on how long the star receiver might be sidelined and what it means for the Vikings' offense going forward.

New coverage reports that heart and kidney complications in patients with type 2 diabetes increase as the disease progresses over time. The finding underscores the cumulative toll of diabetes on cardiovascular and renal health and highlights the importance of long-term monitoring and management of blood sugar, blood pressure and kidney function in affected patients.

Geeta Swamy has been appointed Dean of Boston University's medical school, according to an announcement carried by The American Bazaar. The appointment places an Indian-American physician and academic leader at the head of one of the major US medical institutions. Coverage so far focuses on the announcement itself, with no further details provided in the available reports.

A forum letter in Singapore's The Straits Times argues that patients who combine Western medicine with traditional Chinese medicine should be guided by professional judgment rather than outright prohibitions. The writer says blanket bans ignore real patient behaviour, and that doctors should instead assess interactions and advise patients openly on how to use both systems safely.

A New York Times opinion piece asks why clinical trials for cancer drugs take so long, examining delays in the process of testing new treatments on patients. The article prompts discussion about whether trial design, regulatory requirements, or patient recruitment are the main bottlenecks in getting promising cancer therapies to people faster.

Minnesota Vikings star wide receiver Justin Jefferson has been ruled out for the game against the Tampa Bay Buccaneers due to an ankle injury. His absence is a significant blow to Minnesota's offence, as Jefferson is one of the NFL's top playmakers. Fans and analysts are watching closely for updates on how long he may be sidelined.

Chicago Bears quarterback Tyson Bagent has cleared the NFL's concussion protocol, making him available to return to team activities and potentially game action. The league's protocol requires players to pass a series of supervised steps before being medically cleared following a head injury. His availability gives the Bears added depth at quarterback as they plan for their upcoming games.

Top-ranked Texas, No. 7 Ohio State and No. 11 Texas Tech all kept their perfect records intact in the latest round of college football results, while No. 16 Louisville suffered its first loss of the season. The results reshape the picture near the top of the rankings, with several unbeaten contenders still standing and Louisville now slipping from the unbeaten ranks.

No. 2 Georgia beat Oklahoma 41-13 in a lopsided college football game defined by Oklahoma's turnovers. Linebacker Cole returned a fumble 85 yards for a touchdown, one of the game's highlight plays. Georgia's dominant defense forced repeated mistakes, allowing the Bulldogs to pull away comfortably and reinforce their position near the top of the national rankings.

Ellis Medicine will hold a community forum in Schenectady to discuss the future of healthcare in the area. The event gives residents a chance to hear directly from hospital leadership and raise concerns about local medical services. Details on the date and agenda have been reported by local outlets, drawing attention from community members invested in the hospital's role in the region.

Josh Allen and the Buffalo Bills beat the Los Angeles Chargers 24-16 despite committing five turnovers. The win came despite sloppy play on offense, with the Bills surviving repeated giveaways that would typically prove costly. Buffalo's defense and key plays proved enough to hold off Los Angeles and secure the result.

Southern Cross University is pursuing a strategy in India focused on building a scientific evidence base for traditional medicine. The initiative, reported by BioSpectrum Asia, signals growing collaboration between Australian researchers and India's traditional medicine sector, where validating herbal and ancient practices through rigorous research is an increasing priority for regulators, industry and academia.

Dan Wilson is no longer manager of the Seattle Mariners, the club having parted ways with the former catcher who led the team. The news, first reported by Medicine Hat News, comes as the Mariners make a change at the top of their dugout. Details on the timing of the decision and who might replace Wilson have not yet been announced.

The pairings for Sunday's singles matches at the Presidents Cup at Medinah have been released, setting up the final-day matchups between the United States and the International team. Golf fans are following the announcement closely, as the singles lineup can decide which side lifts the trophy.

A life-size replica of the Yuan dynasty Buddha of Medicine mural is now on display at the National Arts and Crafts Museum in Beijing. The original mural, a celebrated example of Yuan dynasty Buddhist art, depicts the Medicine Buddha surrounded by attendant figures. The exhibition gives visitors the chance to see the work at full scale, drawing attention to the preservation and study of ancient Chinese religious murals.

Health authorities in Kabul have carried out inspections of 75 medicine importers operating in the Afghan capital. The checks are part of regulatory oversight of pharmaceutical imports, a sector long criticised for poor quality control and unlicensed products. Details on findings or penalties were not given in the initial report.

Jadan Baugh and No. 21 Florida overpowered fourth-ranked Ole Miss 52-28 in a college football upset. The Gators' dominant win over a top-five opponent is drawing wide attention, with fans and analysts highlighting Baugh's performance and the damage the result does to Ole Miss's ranking and playoff hopes.

The University of Nebraska Board of Regents has approved the university's representatives to the Nebraska Medicine board, formalizing the governance link between the university system and its academic medical partner in Omaha. The approval was reported by regional outlets serving Nebraska, with coverage noting the routine but significant role these appointments play in oversight of the health system.

The Second Ibero-American Symposium on Ethnoveterinary Medicine is drawing attention, with the Food and Agriculture Organization among those highlighting the event. The gathering brings together researchers and practitioners from across Ibero-America to discuss traditional and plant-based approaches to animal health, and how such knowledge can complement conventional veterinary practice.

Wake Forest beat 16th-ranked Louisville 30-27 in an away game, pulling off one of the notable upsets of the college football weekend. The Demon Deacons took down the ranked Cardinals on their home field, a result that could shake up the Atlantic Coast Conference race and the national rankings.

The University of Nebraska Board of Regents has approved the university's representatives to the Nebraska Medicine board, formalising the institution's seats in the governance of the health system. The approval strengthens the formal ties between the university and Nebraska Medicine, which partners closely with the university's medical centre in Omaha.

Bank of America Corp DE has disclosed a new investment of $9.88 million in Disc Medicine, Inc., the biotech company traded under the ticker IRON. The institutional purchase signals continued interest in the clinical-stage biopharmaceutical firm, whose shares are drawing attention from large asset managers this reporting period.

The University of Nebraska Board of Regents has appointed four new members to the board of Nebraska Medicine, the state's largest health system. The appointments fill seats overseeing the hospital network affiliated with the University of Nebraska Medical Center in Omaha. No further details about the appointees or their terms were immediately available.